These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2418163)

  • 1. A phase I evaluation of poly(I,C)-LC in cancer patients.
    Stevenson HC; Abrams PG; Schoenberger CS; Smalley RB; Herberman RB; Foon KA
    J Biol Response Mod; 1985 Dec; 4(6):650-5. PubMed ID: 2418163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Eastern Cooperative Oncology Group phase I-II pilot study of polyriboinosinic-polyribocytidylic acid poly-L-lysine complex in patients with metastatic malignant melanoma.
    Hawkins MJ; Levin M; Borden EC
    J Biol Response Mod; 1985 Dec; 4(6):664-8. PubMed ID: 2418164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trials of poly(I,C) complexes in advanced cancer.
    Krown SE; Kerr D; Stewart WE; Field AK; Oettgen HF
    J Biol Response Mod; 1985 Dec; 4(6):640-9. PubMed ID: 2418162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
    Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
    J Biol Response Mod; 1985 Oct; 4(5):531-7. PubMed ID: 2416884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
    Levine AS; Sivulich M; Wiernik PH; Levy HB
    Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
    [No Abstract]   [Full Text] [Related]  

  • 6. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
    McFarlin DE; Bever CT; Salazar AM; Levy HB
    J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of poly(I,C)-LC in cancer patients.
    Maluish AE; Reid JW; Crisp EA; Overton WR; Levy H; Foon KA; Herberman RB
    J Biol Response Mod; 1985 Dec; 4(6):656-63. PubMed ID: 4087034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I,C)-LC as an interferon inducer in refractory multiple myeloma.
    Durie BG; Levy HB; Voakes J; Jett JR; Levine AS
    J Biol Response Mod; 1985 Oct; 4(5):518-24. PubMed ID: 3935757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
    Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
    J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of interferon on rabies infection of animals.
    Baer GM
    Tex Rep Biol Med; 1981-1982; 41():526-31. PubMed ID: 6189218
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
    Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
    Cancer Res; 1985 Nov; 45(11 Pt 2):5904-9. PubMed ID: 2414002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
    Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
    Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of an immunotherapeutic protocol with poly(I,C)-LC.
    Talmadge JE; Hartmann D
    J Biol Response Mod; 1985 Oct; 4(5):484-9. PubMed ID: 4078594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
    Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Chirigos M
    Cancer Res; 1985 Mar; 45(3):1066-72. PubMed ID: 3971361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].
    Chirigos MA; Schlick E; Ruffmann R; Budzynski W; Sinibaldi P; Gruys E
    J Biol Response Mod; 1985 Dec; 4(6):621-7. PubMed ID: 4087033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
    Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
    Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I-II trials of poly IC stabilized with poly-L-lysine.
    Levine AS; Levy HB
    Cancer Treat Rep; 1978 Nov; 62(11):1907-12. PubMed ID: 728910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
    Kende M
    J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver enzyme abnormalities after poly ICLC infusions.
    Hess WA; Bever CT; McFarlin DE
    Cancer Treat Rep; 1985 Nov; 69(11):1342. PubMed ID: 2418967
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon induction and therapy of brain tumors in rats by poly(ICLC).
    Machida H; Takezawa J; Kuninaka A; Yoshino H; Nakamura O; Takakura K
    Microbiol Immunol; 1982; 26(4):353-8. PubMed ID: 6180284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.